See every side of every news story
Published loading...Updated

FDA Warns Of Depression, Erectile Dysfunction From Ingredient In Popular Hair-Loss Drugs

  • The FDA issued a public warning on April 22 regarding compounded topical finasteride products for hair loss.
  • This alert follows reports of serious adverse events and notes no FDA-approved topical formulation exists.
  • Compounding pharmacies and online platforms market these unapproved topical finasteride products to consumers.
  • The agency documented 32 adverse event reports tied to these products between 2019 and 2024.
  • The FDA urges healthcare providers inform users about potential harms and the risk of exposing others.
Insights by Ground AI
Does this summary seem wrong?

26 Articles

All
Left
3
Center
4
Right
2
KPVIKPVI
+17 Reposted by 17 other sources
Center

FDA Warns of Unapproved Hair-Loss Product Linked to Side Effects

Key Takeaways

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 44% of the sources are Center
44% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

sherwood.news broke the news in on Tuesday, April 22, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.